Rendering

Component: (Network and Table)
Network
2313301 - Disclosure - Stockholders' Equity (Tables)
(http://www.google.com/role/StockholdersEquityTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Equity [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Equity [Abstract]
 
Schedule of allocated share-based compensation expense
The following table presents our aggregate stock-based compensation expense by type of costs and expenses per the Consolidated Statements of Income (in millions):
 
Year Ended December 31,
 
2014
 
2015
 
2016
Cost of revenues
$
535

 
$
806

 
$
1,157

Research and development
2,200

 
2,687

 
3,354

Sales and marketing
715

 
899

 
1,078

General and administrative
725

 
861

 
1,282

Discontinued operations
104

 
0

 
0

Total stock-based compensation expense
$
4,279

 
$
5,253

 
$
6,871

 
 
Schedule of restricted stock activity
The following table summarizes the activities for our unvested restricted stock units (RSUs) for the year ended December 31, 2016:
 
Unvested Restricted Stock Units
 
    Number of    
Shares
 
Weighted-
Average
Grant-Date
Fair Value
Unvested as of December 31, 2015
25,741,186

 
$
531.74

Granted
13,502,900

 
$
713.89

 Vested
(12,002,071
)
 
$
532.87

 Forfeited/canceled
(1,893,060
)
 
$
562.03

Unvested as of December 31, 2016
25,348,955

 
$
624.92